GO:0070473 negative regulation of uterine smooth muscle contraction: Relaxation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070473 describes any biological process that decreases the frequency, rate, or extent of uterine smooth muscle contraction, commonly referred to as myometrial relaxation.
• The process is essential for maintaining pregnancy, preventing preterm labor, and coordinating the onset of parturition at term.
• Key molecular players include the oxytocin receptor (OXTR), calcium-activated potassium channels (KCa2.3), Rho-kinase, and microRNAs such as miR-203 that modulate contractile machinery.
• Dysregulation of uterine smooth muscle relaxation contributes to preterm birth, primary dysmenorrhea, and labor dystocia.
• Experimental models for studying this process include knockout mice, point-mutation knock-in of contractile proteins, and overexpression of relaxatory channels in uterine smooth muscle cells.
• CRISPR-based editing enables precise interrogation of genes controlling myometrial quiescence and has potential for developing tocolytic therapies.
Description
Uterine smooth muscle contraction is a tightly regulated process that must be suppressed for most of pregnancy to maintain fetal gestation, and then activated at term to facilitate labor. The Gene Ontology term GO:0070473, negative regulation of uterine smooth muscle contraction, captures the biological processes that decrease the frequency, rate, or extent of myometrial contraction. This term is critical for understanding the molecular switches that keep the uterus quiescent and prevent premature labor. Research into this process has revealed a complex interplay of hormonal signals, ion channels, G protein-coupled receptors, and microRNAs that collectively maintain myometrial relaxation. Dysregulation of these pathways is associated with preterm birth, dysmenorrhea, and other reproductive disorders, making this GO term a focal point for both basic and translational research. Understanding the negative regulation of uterine smooth muscle contraction is therefore essential for developing targeted therapies to manage labor timing and treat uterine contractility disorders.
negative regulation of uterine smooth muscle contraction At A Glance
| GO ID | GO:0070473 |
|---|---|
| GO term | negative regulation of uterine smooth muscle contraction |
| Ontology | biological_process |
| Synonym | uterine smooth muscle relaxation; inhibition of uterine smooth muscle contraction; negative regulation of myometrial contraction |
| Major function | Decreases the frequency, rate or extent of uterine smooth muscle contraction, maintaining myometrial quiescence during pregnancy and modulating labor onset |
| Related processes | Regulation of smooth muscle contraction, oxytocin signaling, calcium ion transport, Rho-kinase signaling |
| Key regulators | OXTR, KCa2.3, Rho-kinase, miR-203, M2 macrophages |
| Disease relevance | Preterm birth, primary dysmenorrhea, labor dystocia |
What Is GO:0070473?
GO:0070473 is defined as any process that decreases the frequency, rate or extent of uterine smooth muscle contraction. In other words, it encompasses all molecular and cellular events that promote myometrial relaxation, including the inhibition of contractile signaling pathways, the activation of relaxatory ion channels, and the suppression of genes that drive muscle contraction.
Why Is negative regulation of uterine smooth muscle contraction Important in Cell Biology?
The negative regulation of uterine smooth muscle contraction is fundamental to reproductive biology because it ensures that the uterus remains relaxed throughout gestation, preventing preterm labor, and then allows for timely contraction at parturition. Disruptions in this process can lead to serious clinical outcomes, including preterm birth, which is a leading cause of neonatal morbidity and mortality, and primary dysmenorrhea, which affects millions of women worldwide. Understanding the molecular mechanisms that suppress myometrial contraction provides insights into potential therapeutic targets for tocolytic drugs and for managing labor complications.
• Maintains uterine quiescence during pregnancy to prevent miscarriage and preterm labor.
• Coordinates the timing of labor onset by balancing contractile and relaxatory signals.
• Involved in the pathophysiology of primary dysmenorrhea, where excessive contraction causes pain.
• Provides molecular targets for tocolytic therapies aimed at delaying preterm birth.
• Regulated by hormones such as oxytocin and progesterone, which are critical for reproductive health.
• Modulated by ion channels like KCa2.3, which are potential drug targets for uterine relaxation.
• Influenced by immune cells such as M2 macrophages undergoing ferroptosis, linking inflammation to labor.
• Epigenetically regulated by microRNAs such as miR-203, offering new avenues for therapeutic intervention.
• Dysregulation is associated with labor dystocia and postpartum hemorrhage.
• Studying this process aids in understanding smooth muscle physiology across other organ systems.
What Happens During negative regulation of uterine smooth muscle contraction?
Hormonal and Receptor-Mediated Relaxation
In simple terms: Hormones and their receptors act as brakes on uterine muscle contraction.
The oxytocinergic system plays a dual role in uterine contractility; while oxytocin stimulates contraction, negative regulation involves the downregulation of oxytocin receptor (OXTR) signaling or the activation of relaxatory pathways. For example, G protein-coupled receptor kinase 2 (GRK2) selectively regulates H1 histamine receptor signaling in uterine smooth muscle cells, which can modulate contractile responses. Additionally, progesterone and other hormones promote myometrial quiescence by suppressing contractile gene expression.
Ion Channel Modulation and Calcium Handling
In simple terms: Ion channels control the electrical activity that triggers muscle contraction, and their activation can relax the uterus.
Calcium-activated potassium channels, such as KCa2.3, provide a negative feedback mechanism to limit oxytocin-stimulated contractions. Augmented KCa2.3 channel activity reduces membrane excitability and promotes relaxation. Similarly, the transient receptor potential vanilloid 4 (TRPV4) channel is modulated by miR-203, which affects myometrial contractility; downregulation of TRPV4 by miR-203 leads to decreased contractility.
Rho-Kinase and Myosin Light Chain Phosphatation
In simple terms: Enzymes that control the phosphorylation of myosin, the motor protein of muscle, can be inhibited to reduce contraction.
Rho-kinase mediates diphosphorylation of the myosin regulatory light chain in cultured uterine smooth muscle cells, contributing to sustained contraction. Inhibition of Rho-kinase activity promotes relaxation by reducing myosin light chain phosphorylation. This pathway is a key target for negative regulation of uterine smooth muscle contraction.
Immune and Inflammatory Modulation
In simple terms: Immune cells can release signals that either promote or inhibit uterine contraction.
M2 macrophages undergoing ferroptosis regulate uterine smooth muscle contraction to facilitate labor onset. Their depletion or modulation can alter the timing of labor, indicating a role in the negative regulation of contraction during pregnancy. Inflammatory mediators can also affect contractility, as seen in primary dysmenorrhea where exercise modulates inflammation and hormone levels to reduce symptoms.
MicroRNA and Epigenetic Regulation
In simple terms: Small RNA molecules can fine-tune the expression of genes that control uterine contraction.
miR-203 modulates pregnant myometrium contractility by targeting TRPV4 channel expression. Overexpression of miR-203 reduces TRPV4 levels and decreases contractility, demonstrating a role in negative regulation. Other microRNAs may similarly influence the expression of contractile-associated proteins.
Key Genes Involved in GO:0070473 negative regulation of uterine smooth muscle contraction
The following genes and proteins are central to the negative regulation of uterine smooth muscle contraction, based on experimental evidence from published studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| OXTR | Oxytocin receptor; mediates oxytocin-induced contraction, but its downregulation promotes relaxation | Target for tocolytic drugs; knockout models show delayed labor |
| KCNN3 (KCa2.3) | Calcium-activated potassium channel; activation hyperpolarizes membrane and reduces contraction | Overexpression or pharmacological activation induces relaxation |
| RHOA/ROCK | Rho-kinase pathway; mediates myosin light chain phosphorylation and sustained contraction | Inhibition promotes relaxation; knockout reduces contractility |
| TRPV4 | Transient receptor potential vanilloid 4 channel; modulates calcium influx and contractility | Target of miR-203; knockdown reduces contraction |
| MIR203 | MicroRNA that downregulates TRPV4, reducing myometrial contractility | Overexpression decreases contraction; potential therapeutic |
| GRK2 | G protein-coupled receptor kinase 2; regulates H1 histamine receptor signaling | Modulates histamine-induced contraction in uterine smooth muscle cells |
| MYL9 | Myosin regulatory light chain; phosphorylation drives contraction | Diphosphorylation by Rho-kinase; target for relaxation |
| MYH11 | Smooth muscle myosin heavy chain; essential for contraction | Mutations affect contractility; knockout lethal |
| ACTA2 | Alpha-smooth muscle actin; component of contractile apparatus | Expression changes alter contractile force |
| CALD1 | Caldesmon; regulates actin-myosin interaction | Phosphorylation state affects relaxation |
| PPP1R12A | Myosin phosphatase target subunit; dephosphorylates myosin light chain | Activation promotes relaxation |
| GNAQ | G protein alpha q; mediates oxytocin and other contractile signals | Knockout reduces contraction |
| PLCB1 | Phospholipase C beta 1; generates IP3 and DAG for calcium release | Inhibition reduces contraction |
| ITPR1 | Inositol 1,4,5-trisphosphate receptor; releases calcium from stores | Blockade reduces contraction |
| CACNA1C | Voltage-gated calcium channel; mediates calcium influx for contraction | Blockers used as tocolytics |
| ATP2B1 | Plasma membrane calcium ATPase; extrudes calcium to promote relaxation | Overexpression enhances relaxation |
| NOS1 | Neuronal nitric oxide synthase; produces NO to relax smooth muscle | NO donors promote uterine relaxation |
| GUCY1A1 | Guanylate cyclase; mediates NO-induced relaxation via cGMP | Activation promotes relaxation |
How Is negative regulation of uterine smooth muscle contraction Regulated?
The negative regulation of uterine smooth muscle contraction is controlled by a network of hormonal, inflammatory, and epigenetic signals. Oxytocin and progesterone balance contractile and relaxatory tone, with progesterone promoting quiescence. Inflammatory mediators from M2 macrophages can influence labor onset, and their ferroptosis modulates contraction. MicroRNAs such as miR-203 provide post-transcriptional regulation of contractile genes. Additionally, ion channels like KCa2.3 are regulated by feedback mechanisms to limit contraction. This multi-layered regulation ensures proper timing of labor.
negative regulation of uterine smooth muscle contraction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| OXTR | Preterm birth, labor dystocia | Knockout mouse; point mutation in OXTR |
| KCNN3 | Preterm birth, uterine hypercontractility | Overexpression in uterine smooth muscle cells |
| TRPV4 | Dysmenorrhea, preterm labor | miR-203 overexpression; TRPV4 knockout |
| RHOA/ROCK | Labor dystocia, hypertension in pregnancy | Rho-kinase inhibitor treatment; knockout |
| M2 macrophages | Labor onset timing | Ferroptosis induction; macrophage depletion |
Preterm Birth and Labor Dystocia
Preterm birth occurs when the negative regulation of uterine smooth muscle contraction fails, leading to premature myometrial activation. Comparative studies on labor initiation highlight the importance of maintaining uterine quiescence. Dysregulation of oxytocin signaling or ion channels can contribute to preterm labor. Conversely, excessive relaxation can lead to labor dystocia, requiring medical intervention.
Primary Dysmenorrhea
Primary dysmenorrhea is characterized by painful uterine contractions during menstruation. Exercise interventions such as sprint-interval training on a spinning bike have been shown to ameliorate symptoms through hormone and inflammation modulations, indirectly supporting the role of negative regulation of contraction in reducing pain.
Uterine Fibroids and Other Reproductive Disorders
Although not directly studied in the context of GO:0070473, uterine fibroids and endometriosis involve abnormal smooth muscle contractility. Modulators of the Rho-kinase pathway and ion channels may offer therapeutic benefits.
From negative regulation of uterine smooth muscle contraction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X inhibit uterine contraction? | Knockout of gene X in mice or uterine smooth muscle cells |
| Does a point mutation in gene Y alter relaxation? | Point-mutation knock-in via CRISPR in myometrial cells |
| Can overexpression of gene Z promote relaxation? | Overexpression of gene Z in uterine smooth muscle cells |
| What is the role of a specific microRNA? | Knock-in of miRNA mimic or antagomir in pregnant mice |
| How does immune cell modulation affect contraction? | Macrophage depletion or ferroptosis induction in pregnant mice |
| Does a channel activator relax the uterus? | Tagged knock-in of channel for imaging; pharmacological activation |
How to Study the negative regulation of uterine smooth muscle contraction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Organ bath contractility | Force of uterine smooth muscle contraction | Testing tocolytic drugs or genetic modifications |
| Calcium imaging | Intracellular calcium concentration | Assessing ion channel function |
| Patch-clamp electrophysiology | Membrane potential and ion currents | Studying KCa2.3 and TRPV4 channels |
| RNA-seq | Global gene expression changes | Identifying relaxatory pathways |
| qPCR | Expression of specific genes/miRNAs | Validating miR-203 targets |
| Western blot | Protein phosphorylation and expression | Measuring myosin light chain phosphorylation |
| Immunohistochemistry | Localization of proteins in tissue | Detecting OXTR or KCa2.3 in myometrium |
| CRISPR screening | Gene function in contractility | Identifying novel regulators |
In Vitro Contractility Assays
Uterine strips from animal models or human biopsies can be mounted in organ baths to measure isometric force in response to oxytocin or other stimuli. This method directly assesses the negative regulation of contraction by test compounds or genetic modifications.
Calcium Imaging and Electrophysiology
Calcium imaging using fluorescent dyes and patch-clamp electrophysiology measure intracellular calcium levels and membrane potential in uterine smooth muscle cells. These techniques reveal how ion channels and signaling pathways modulate contractility.
Gene Expression and MicroRNA Profiling
RNA-seq and qPCR can quantify mRNA levels of contractile-associated genes and microRNAs such as miR-203. This helps identify molecular changes that promote relaxation.
Protein Phosphorylation Analysis
Western blotting with phospho-specific antibodies detects phosphorylation of myosin light chain and other regulatory proteins, providing insight into Rho-kinase and myosin phosphatase activity.
How CRISPR Can Be Used to Study GO:0070473 negative regulation of uterine smooth muscle contraction
Knockout
CRISPR knockout of genes such as OXTR, KCNN3, or RHOA in uterine smooth muscle cells or mouse models can reveal their essential roles in negative regulation of contraction. For example, knockout of KCa2.3 would be expected to enhance contractility.
Point Mutation
Introducing point mutations in contractile proteins like MYL9 or ion channels can mimic human variants associated with preterm labor or dysmenorrhea. This allows precise dissection of phosphorylation sites or channel gating.
Knock-in
Knock-in of tagged versions of proteins (e.g., GFP-KCa2.3) enables live-cell imaging of channel localization and dynamics. Knock-in of miR-203 target sites can validate microRNA regulation.
Overexpression
Overexpression of relaxatory genes such as KCNN3 or MIR203 in uterine smooth muscle cells can promote quiescence. This approach is useful for testing therapeutic candidates.
How EDITGENE Supports negative regulation of uterine smooth muscle contraction Research
Researchers studying negative regulation of uterine smooth muscle contraction-related genes often need to determine whether a candidate gene is causally involved in myometrial relaxation or whether its manipulation can prevent preterm labor. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of uterine smooth muscle contraction research.
Frequently Asked Questions About negative regulation of uterine smooth muscle contraction
What is GO:0070473?
GO:0070473 is the Gene Ontology term for negative regulation of uterine smooth muscle contraction, defined as any process that decreases the frequency, rate or extent of uterine smooth muscle contraction.
What genes are involved in negative regulation of uterine smooth muscle contraction?
Key genes include OXTR, KCNN3 (KCa2.3), RHOA/ROCK, TRPV4, and MIR203, among others.
How does oxytocin affect uterine smooth muscle contraction?
Oxytocin stimulates contraction via OXTR, but negative regulation can occur through downregulation of OXTR signaling or activation of relaxatory pathways.
What is the role of KCa2.3 channels in uterine relaxation?
KCa2.3 channels provide negative feedback to limit oxytocin-stimulated contractions by hyperpolarizing the membrane.
How does miR-203 modulate myometrial contractility?
miR-203 downregulates TRPV4 channel expression, leading to decreased myometrial contractility.
What diseases are associated with impaired uterine relaxation?
Preterm birth, primary dysmenorrhea, and labor dystocia are associated with dysregulation of uterine smooth muscle relaxation.
Can CRISPR be used to study uterine smooth muscle contraction?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect gene function in uterine smooth muscle cells.
What experimental models are used to study negative regulation of uterine contraction?
Organ bath contractility assays, calcium imaging, electrophysiology, and genetically modified mice are commonly used.
How do M2 macrophages influence uterine contraction?
M2 macrophages undergoing ferroptosis regulate uterine smooth muscle contraction to facilitate labor onset.
What is the role of Rho-kinase in uterine contraction?
Rho-kinase mediates myosin light chain phosphorylation, promoting sustained contraction; its inhibition promotes relaxation.
Conclusion
The negative regulation of uterine smooth muscle contraction (GO:0070473) is a critical biological process that maintains myometrial quiescence during pregnancy and modulates labor onset. Dysregulation of this process contributes to preterm birth, dysmenorrhea, and other reproductive disorders. Advances in CRISPR gene editing and functional genomics are enabling precise dissection of the molecular players involved, offering hope for new therapeutic strategies. EDITGENE provides comprehensive services to support research in this field, from knockout models to CRISPR screening and bioinformatics.
References
- 1. Song L et al.. 2025. M2 macrophages undergoing ferroptosis regulate uterine smooth muscle contraction to facilitate labor onset.. Sci Rep 15(1):45152 PMID: 41429871
- 2. Huang WC et al.. 2022. The Sprint-Interval Exercise Using a Spinning Bike Improves Physical Fitness and Ameliorates Primary Dysmenorrhea Symptoms Through Hormone and Inflammation Modulations: A Randomized Controlled Trial.. J Sports Sci Med 21(4):595-607 PMID: 36523895
- 3. Willets JM et al.. 2008. Selective regulation of H1 histamine receptor signaling by G protein-coupled receptor kinase 2 in uterine smooth muscle cells.. Mol Endocrinol 22(8):1893-907 PMID: 18511496
- 4. Hasan R. 2024. The Multifaceted Role of Oxytocinergic System and OXTR Gene.. Glob Med Genet 11(1):29-33 PMID: 38239807
- 5. Zak M et al.. 2021. Augmented K(Ca)2.3 Channel Feedback Regulation of Oxytocin Stimulated Uterine Strips from Nonpregnant Mice.. Int J Mol Sci 22(24) PMID: 34948381
- 6. Nathanielsz PW. 1998. Comparative studies on the initiation of labor.. Eur J Obstet Gynecol Reprod Biol 78(2):127-32 PMID: 9622309
- 7. Aguilar HN et al.. 2012. Rho-kinase mediates diphosphorylation of myosin regulatory light chain in cultured uterine, but not vascular smooth muscle cells.. J Cell Mol Med 16(12):2978-89 PMID: 22947248
- 8. Ying L et al.. 2024. miR-203 modulates pregnant myometrium contractility via transient receptor potential vanilloid 4 channel expression.. FASEB J 38(22):e70173 PMID: 39545721
